Vipin K. Garg - 27 Jan 2026 Form 4 Insider Report for Altimmune, Inc. (ALT)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
29 Jan 2026, 16:10:07 UTC
Prior SEC filing
27 Jan 2026
Next SEC filing
02 Feb 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Gregory Weaver, as Attorney-in-Fact

Key filing fact

Vipin K. Garg filed Form 4 for Altimmune, Inc. (ALT) on 29 Jan 2026.

Key facts

  • This page summarizes Vipin K. Garg's Form 4 filing for Altimmune, Inc. (ALT).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 29 Jan 2026, 16:10.

Change

  • Previous filing in this sequence was filed on 27 Jan 2026.
  • Current net transaction value: -$110,610.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001515813 Primary reporting owner

Garg Vipin K

Relationship
Director
Address
910 CLOPPER ROAD, SUITE 201S, GAITHERSBURG
Signature
/s/ Gregory Weaver, as Attorney-in-Fact
Signature date
29 Jan 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ALT transaction

Common Stock, par value $0.0001

Options Exercise

Transaction value
$0
Shares
+41,200
Change %
+11%
Price
$0.000000
Shares after
420,348
Date
27 Jan 2026
Ownership
Direct
Footnotes
F1
ALT transaction

Common Stock, par value $0.0001

Tax liability

Transaction value
$110,610
Shares
-17,898
Change %
-4.3%
Price
$6.18
Shares after
402,450
Date
27 Jan 2026
Ownership
Direct
Footnotes
F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ALT transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-41,200
Change %
-25%
Price
$0.000000
Shares after
123,600
Date
27 Jan 2026
Ownership
Direct
Underlying class
Common Stock, par value $0.0001
Underlying amount
41,200
Exercise price
Footnotes
F1, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested.

Footnote F2

Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of RSUs.

Footnote F3

The RSUs vest in substantially equal annual installments over the 4 years following January 27, 2025, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .